Marksans Pharma voluntarily recalled a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg (Lot # XP9004), distributed by Time-Cap Labs Inc.
Learn more
Lupin Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg (Lot G901203, Expiration December 2020). On July 8, 2020 Lupin announced that it was voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg within expiry.
Learn more
Major Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg. This lot (Lot#: T-02134, Expiration 09/30/20) was tested and showed results for NDMA, an unexpected impurity, at levels in excess of acceptable limits. Major has agreed to recall this lot.
Learn more
Major Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg. This lot (Lot#: T-02134, Expiration 09/30/20) was tested and showed results for NDMA, an unexpected impurity, at levels in excess of acceptable limits. Major has agreed to recall this lot.
Learn more
Avkare is voluntarily recalling all non-expired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg distributed in the United States that were manufactured by Amneal Pharmaceuticals.
Learn more
Lupin Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg (Lot G901203, Expiration December 2020).
Learn more